Can Aortic Stenosis Be Managed To Prevent Further Heart Enlargement?

  • Ayan Younis BSc Biomedical Science, Queen Mary University of London

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative

Introduction

Aortic stenosis (AS) is a common condition affecting the heart’s aortic valve, leading to its narrowing and ultimately increasing the heart's workload. As the heart strains to pump blood through a narrowed valve, the left ventricle often becomes thicker and enlarged over time, potentially leading to severe complications like heart failure and arrhythmias. Understanding how to manage aortic stenosis is crucial in preventing the progression of heart enlargement. This essay explores how medications, lifestyle adjustments, regular monitoring, and surgical options are employed in managing aortic stenosis and minimising heart enlargement, providing a comprehensive approach for patients and healthcare providers.

Background of aortic stenosis and heart enlargement

Aortic stenosis primarily results from calcification due to ageing or congenital anomalies like a bicuspid aortic valve, causing it to narrow over time.1 When the valve opening becomes too small, the heart's left ventricle must work harder, leading to hypertrophy or the thickening of the heart muscle. This enlargement is an adaptive response to increased workload but becomes maladaptive over time, potentially leading to heart failure and arrhythmias.2

The development of heart enlargement in aortic stenosis patients is gradual, often progressing over years. Patients may remain asymptomatic during early stages, but the condition can rapidly worsen without effective management. Interventions to slow or prevent heart enlargement are essential to maintaining heart function, quality of life, and survival rates among affected patients.3

Effective management strategies for aortic stenosis

Medication

Medications can significantly alleviate symptoms and reduce heart strain, although they do not cure the underlying valve narrowing. The primary goal of medication therapy is to manage blood pressure and reduce the burden on the heart’s left ventricle.4 The following are some key medications used in managing aortic stenosis:

  • ACE Inhibitors: ACE inhibitors, such as enalapril and lisinopril, relax blood vessels and lower blood pressure. While their primary use is in hypertension and heart failure, they are beneficial for aortic stenosis by reducing the left ventricular workload5
  • Beta-Blockers: Medications like metoprolol and atenolol help slow down the heart rate, which can reduce the frequency of angina and control symptoms of heart failure. By reducing heart rate and myocardial oxygen demand, beta-blockers prevent further strain on the heart6
  • Diuretics: For patients experiencing symptoms of heart failure, diuretics are commonly prescribed to reduce fluid retention, decrease blood pressure, and ease the workload on the heart7

Medications are tailored based on individual patient needs and disease progression. While effective in symptom management, medications are typically supplementary to other strategies due to their limited impact on valve function.

Lifestyle adjustments

Lifestyle changes are essential for managing aortic stenosis and preventing further heart enlargement. These adjustments focus on reducing the heart's overall workload and promoting vascular health to ensure optimal function despite the narrowed aortic valve.

  1. Heart-Healthy Diet: A diet rich in fruits, vegetables, whole grains, and lean proteins and low in saturated fats, cholesterol, and sodium can help manage weight, blood pressure, and cholesterol levels. It can also reduce the strain on the cardiovascular system and prevent further heart enlargement in patients with aortic stenosis8
  2. Safe Exercise: While excessive physical exertion can increase strain on the heart, moderate exercise under medical supervision can improve cardiovascular function and manage weight. Walking, swimming, or cycling at a low intensity is generally recommended for AS patients, as these activities promote circulation without overburdening the heart9
  3. Smoking Cessation: Smoking exacerbates cardiovascular disease by contributing to plaque formation, which can aggravate valve calcification and stenosis. Quitting smoking is crucial to prevent further narrowing of the valve and slow the progression of left ventricular hypertrophy10
  4. Weight Management: Obesity places additional stress on the heart and is a risk factor for hypertension and cardiovascular diseases. Maintaining a healthy weight can ease the heart’s workload, potentially delaying the need for surgical intervention11

Regular monitoring

Regular monitoring is vital for assessing the progression of aortic stenosis and the extent of heart enlargement. Echocardiography is commonly used to evaluate valve structure, measure gradients, and consider the left ventricle's function and size. At the same time, other methods like electrocardiograms (ECGs) and cardiac magnetic resonance imaging (MRI) may also be helpful in specific cases.12

  • Annual Check-Ups for Mild to Moderate Cases: Annual echocardiograms are recommended for individuals with mild or moderate aortic stenosis to track disease progression. This helps in timely adjustments of medications and lifestyle recommendations as the condition evolves13
  • Frequent Monitoring for Severe Cases: In severe aortic stenosis cases, more frequent follow-ups are necessary, sometimes every six months. Regular evaluation allows healthcare providers to detect any worsening heart enlargement, enabling timely surgical referral if needed14

Monitoring aids in the early detection of heart failure symptoms and ensures that intervention occurs promptly, reducing the risk of irreversible heart damage.

Surgical options

For patients with severe aortic stenosis, surgery may be essential to alleviate the obstruction and prevent further complications. Surgical intervention is often the most effective way to prevent heart enlargement and the associated risks of left ventricular dysfunction and heart failure.

  1. Aortic Valve Replacement (AVR): Surgical aortic valve replacement is the traditional treatment for severe AS and involves replacing the narrowed valve with a mechanical or bioprosthetic valve. This procedure restores normal blood flow, relieves the left ventricular workload, and reduces the risk of heart enlargement15
  2. Transcatheter Aortic Valve Replacement (TAVR): TAVR is a less invasive alternative to AVR for high-risk patients for open-heart surgery. It involves inserting a new valve through a catheter, usually via the femoral artery. TAVR is particularly suitable for elderly patients and those with co-morbidities, offering a shorter recovery time and lower risk of complications compared to open surgery16
  3. Balloon Valvuloplasty: In cases where surgery is not feasible, balloon valvuloplasty may be performed. This procedure involves inflating a balloon within the valve to temporarily widen it. While less permanent than AVR or TAVR, balloon valvuloplasty can relieve symptoms and delay the need for more invasive intervention17

Each of these surgical options aims to relieve the obstruction caused by aortic stenosis, reduce the workload on the left ventricle, and ultimately prevent further enlargement.

Importance of patient education and support

Educating patients about their condition and involving them in the management process is essential to successful aortic stenosis management. By understanding the impact of lifestyle choices and adhering to recommended medical treatments, patients are empowered to take control of their health. Support from family, caregivers, and healthcare professionals also plays a key role in ensuring patients adhere to lifestyle modifications and seek timely medical advice.

Furthermore, psychological support is crucial, especially for older patients and those undergoing significant surgeries like TAVR or AVR. Addressing fears about surgery and providing clear information on what to expect can significantly improve the overall care experience and outcomes.18

Summary

In summary, managing aortic stenosis effectively can significantly reduce the risk of further heart enlargement and improve patient outcomes. Key strategies include medications to reduce heart strain, lifestyle changes to support cardiovascular health, regular monitoring to detect disease progression, and surgical intervention when necessary. By combining these approaches, patients can achieve improved heart function, fewer symptoms, and enhanced quality of life.

FAQs

Can medication alone manage aortic stenosis effectively?

Medication can relieve symptoms and reduce heart strain but does not cure valve narrowing. Severe cases may still require surgical intervention.

How often should aortic stenosis be monitored?

Mild to moderate cases are usually monitored annually, while severe cases may require more frequent check-ups to detect progression.

Is TAVR suitable for all patients with severe aortic stenosis?

TAVR is ideal for patients at high surgical risk, such as the elderly or those with other health conditions, but may not be suitable for everyone.

What lifestyle changes can help manage aortic stenosis?

A heart-healthy diet, safe exercise, smoking cessation, and maintaining a healthy weight are crucial lifestyle adjustments to manage AS effectively.

References

  1. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2017;135(25)
  2. Carabello BA, Paulus WJ. Aortic stenosis. The Lancet. 2009;373(9667):956-966.
  3. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607.
  4. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary. Circulation. 2014;129(23):2440-2492.
  5. Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H, et al. Mild and moderate aortic stenosis: Natural history and risk stratification by echocardiography. Eur Heart J. 2004;25(3):199-205.
  6. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33(19):2451-2496.
  7. Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald’s heart disease: A textbook of cardiovascular medicine. 11th ed. Philadelphia: Elsevier; 2019.
  8. Otto CM. Valvular heart disease: a companion to Braunwald’s heart disease. 5th ed. Philadelphia: Elsevier; 2020.
  9. Nishimura RA, O’Gara PT, Bonow RO. Clinical practice guidelines for valvular heart disease: past, present, and future. JAMA Cardiol. 2021;6(6):732-740.
  10. Webb JG, Dvir D. Transcatheter aortic valve replacement for severe aortic stenosis: patient selection and clinical outcomes. Circ Res. 2017;120(8):1127-1138.
  11. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol. 2012;60(19):1854-1863.
  12. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-2791.
  13. Arora S, Misenheimer JA, Ramaraj R. Transcatheter aortic valve replacement: comprehensive review and present status. Tex Heart Inst J. 2017;44(1):29-37.
  14. Tarantini G, Nai Fovino L, Tellaroli P, Scotti A, De Beni S, Razzolini R, et al. Prognostic impact of left ventricular hypertrophy on outcomes after transcatheter aortic valve replacement for severe aortic stenosis. JACC Cardiovasc Interv. 2018;11(5):557-568.
  15. Blackstone EH, Suri RM, Rajeswaran J, Kapadia S, Tuzcu EM, Svensson LG, et al. Propensity-matched comparisons of clinical outcomes after mechanical or bioprosthetic aortic valve replacement: a class effect of an entire generation of prostheses. Eur Heart J. 2015;36(16):1046-1054.
  16. Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, et al. Transcatheter aortic valve replacement vs. surgical valve replacement in intermediate-risk patients: A propensity score analysis. Lancet. 2016;387(10034):2218-2225.
  17. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321-1331.
  18. Suri RM, Schaff HV, Dearani JA, Joyce LD, Burkhart HM, Daly RC, et al. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in older patients. Ann Thorac Surg. 2006;82(2):819-826.

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative
[optin-monster-inline slug="yw0fgpzdy6fjeb0bbekx"]
This content is purely informational and isn’t medical guidance. It shouldn’t replace professional medical counsel. Always consult your physician regarding treatment risks and benefits. See our editorial standards for more details.

Get our health newsletter

Get daily health and wellness advice from our medical team.
Your privacy is important to us. Any information you provide to this website may be placed by us on our servers. If you do not agree do not provide the information.

Mezad Firdosh Zaiwala

Master's degree, Public Health, University of Bristol

With a background in veterinary medicine and a Master's in Public Health, Mezad Zaiwala embodies a unique blend of expertise in animal care and public health advocacy. Their journey began in veterinary clinics, where they cultivated their clinical skills and nurtured a deep connection with animals and their caregivers.

Driven by a desire to address broader health challenges, Mezad Zaiwala pursued a Master's degree in Public Health, delving into topics such as epidemiology, health policy, and environmental health. This interdisciplinary education equipped them with a comprehensive understanding of the intricate relationship between animal health, human health, and environmental factors.

my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818
arrow-right